NATIONAL BANK OF CANADA /FI/
BankPosition in NAMS — NewAmsterdam Pharma Co N.V.
CIK 926171
MONTREAL, A8
Position in NAMS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$61,442
-$3,122 QoQ
Shares Held
1,813
-10.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#170
of 198 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NAMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIONAL BANK OF CANADA /FI/ holds $632,188,402 across 150 Biotechnology names. NAMS ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
1,096,025 | $205,263,562 | |
| 2 | MRNA |
Moderna, Inc.
|
1,424,802 | $99,778,883 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
2,773,874 | $98,167,400 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
172,898 | $85,883,622 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
125,812 | $78,448,813 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
52,467 | $15,794,140 | |
| 7 | GPCR |
Structure Therapeutics Inc.
|
215,800 | $11,581,986 | |
| 8 | ABCL |
AbCellera Biologics Inc.
|
1,233,014 | $9,679,159 |
All Filings in NAMS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,442 | 1,813 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $64,564 | 2,017 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $70,756 | 2,017 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $55,429 | 1,949 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $35,875 | 1,981 | Shares | Defined | 2025-08-18 | |
| 2025-03-31 | $37,501 | 1,832 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $51,400 | 2,000 | Shares | Defined | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||